Century Therapeutics, Inc. - יחס שווי פעילות למכירות IPSC

לוגו של חברה ציבורית Century Therapeutics (IPSC)

Data analysis automation and screening robotization will accelerate drug delivery, as confirmed by the shift in the EV/Sales valuation on the GURU.Markets chart, where 0.00 characterizes this valuation parameter for Century Therapeutics (IPSC). The company's foundation is supported by its own sterile facilities in New Jersey and a complex cryogenic air delivery system for biomaterials to maintain their viability.

Century Tx (IPSC): יחס שווי פעילות להכנסות מ-23.11.2025 עד 20.11.2026

פילוחי מדדים פיננסיים ומדדי שוק עבור Century Therapeutics, Inc. (IPSC)

הערכת שווי פונדמנטלית:Century Tx (IPSC)
מוצר עיקרי של centurytx.com

Century Therapeutics' ability to withstand market volatility is determined by the efficiency of its iPSC platform and the support of Bayer in developing solid tumor therapies. An analysis of the Enterprise Value-to-Revenue (EV/Revenue) multiple allows for a valuation of the business regardless of debt load, demonstrating how market capitalization correlates with actual sales amid tight Fed policy, which is critical for determining the asset's fundamental stability.